Is Erythropietin effective on preventing Cisplatin induced nephropathy?

Not Applicable

• Conditions: Renal failure.; Renal failure; N17-N19

• Registration Number: IRCT201202158397N3
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

(to have indication for chemotherapy with cisplatine alone or together with other agents)
Exclusion criteria: (to have a history of parior chemotherapy or history of prior erythropoietin consumption; to recieve another concurrent nephrotoxic agent; to have clues of renal failure)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood creatinine level. Timepoint: 24 hours before the start of chemotherapy, in first day, second day, fourth day and 24 hours after the end of chemotherapy. Method of measurement: Laboratory testing.;Blood magnesium level. Timepoint: 24 hours before the start of chemotherapy, in first day, second day, fourth day and 24 hours after the end of chemotherapy. Method of measurement: Laboratory testing.;24-hour urine creatinine level. Timepoint: 24 hours before the start of chemotherapy, in first day, second day, fourth day and 24 hours after the end of chemotherapy. Method of measurement: Laboratory testing.;Blood Urea Nitrogen level. Timepoint: 24 hours before the start of chemotherapy, in first day, second day, fourth day and 24 hours after the end of chemotherapy. Method of measurement: Laboratory testing.